Significance of galactomannan antigen for aspergillosis diagnosis: A review

Authors

  • Esmaeill Mortaz Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Mehdi Taghavi Mycology Research Center, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
  • Shamsadin Athari Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Abstract:

Invasive aspergillosis is one the major causes of death in hematopoietic and solidtransplantrecipients. One of the most critical problems in medical mycology is theinability to consistently make a convincing and early diagnosis of invasive fungalinfection. Conventional diagnosis methods such as culture-based approaches are limitedby the insufficient accessibility sensitivity and the non-culture-based approaches based onthe detection of specific fungal antigens, fungal metabolites, and fungal DNA are limitedby the slow speed of analysis. Early diagnosis of invasive aspergillosis is the maincomplication in its treatment. Galactomannan is a polysaccharide present in the cell wallof Aspergillus species. This carbohydrate is released into the serum during the invasion ofAspergillus. Recently, a double-sandwich enzyme-linked immunosorbent assay (ELISA)was developed for detecting galactomannan antigenemia in the serum. This assay is animportant advancement in the nonculture diagnosis of invasive aspergillosis. The level ofgalactomannan in the serum may be an important indication of therapeutic response. Inthis review, the role of galactomannan in the diagnosis of IA and its significance has beenhighlighted.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

significance of galactomannan antigen for aspergillosis diagnosis: a review

invasive aspergillosis is one the major causes of death in hematopoietic and solidtransplantrecipients. one of the most critical problems in medical mycology is theinability to consistently make a convincing and early diagnosis of invasive fungalinfection. conventional diagnosis methods such as culture-based approaches are limitedby the insufficient accessibility sensitivity and the non-culture...

full text

Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis.

Diagnosing chronic pulmonary aspergillosis (CPA) is complicated, and there are limited data available regarding the identification of galactomannan (GM) in clinical specimens to assist the detection of this infection. The purpose of this study was to evaluate the detection of GM in bronchoalveolar lavage fluid (BALF) and serum and to assess its utility for diagnosing CPA. We retrospectively rev...

full text

Bronchoalveolar Lavage Fluid Galactomannan for Diagnosis of Invasive Pulmonary Aspergillosis

To the Editor—We read the article by Maertens et al [1] with great interest. In a series of 58 patients who received a diagnosis of proven or probable invasive aspergillosis (IA), the authors confirmed previous work that the diagnostic performance of galactomannan antigen levels in bronchoalveolar lavage (BAL) fluid samples is good and that the procedure is safe in critically ill hematology pat...

full text

Bronchoalveolar lavage fluid galactomannan for diagnosis of invasive pulmonary aspergillosis.

To the Editor—We read the article by Maertens et al [1] with great interest. In a series of 58 patients who received a diagnosis of proven or probable invasive aspergillosis (IA), the authors confirmed previous work that the diagnostic performance of galactomannan antigen levels in bronchoalveolar lavage (BAL) fluid samples is good and that the procedure is safe in critically ill hematology pat...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 2  issue 2

pages  111- 117

publication date 2015-07-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023